Intervention Review

A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS

  1. Muki Shey1,*,
  2. Eugene J Kongnyuy2,
  3. Judith Shang3,
  4. Charles Shey Wiysonge1

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 9 MAY 2009

DOI: 10.1002/14651858.CD005481.pub2

How to Cite

Shey M, Kongnyuy EJ, Shang J, Wiysonge CS. A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD005481. DOI: 10.1002/14651858.CD005481.pub2.

Author Information

  1. 1

    University of Cape Town, Institute of Infectious Disease and Molecular Medicine (IIDMM), Cape Town, South Africa

  2. 2

    Liverpool School of Tropical Medicine, Child and Reproductive Health Group, Liverpool, UK

  3. 3

    University of Yaounde, Yaounde, Cameroon

*Muki Shey, Institute of Infectious Disease and Molecular Medicine (IIDMM), University of Cape Town, Anzio Road, Observatory, Cape Town, 7925, South Africa. shehushey@yahoo.fr.

Publication History

  1. Publication Status: New
  2. Published Online: 8 JUL 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >